Polygenic prediction of coronary artery disease among 130,000 Mexican adults

Tong Liu(Jianghan University), Roberto Tapia‐Conyer(Secretaria de Salud), Juan Pablo Torres(Universidad de Santiago de Chile), Jonathan Emberson(University of Oxford), Jesús Alegre-Díaz(Universidad Nacional Autónoma de México), Jaime Berúmen(Yale University), Raúl Ramírez-Reyes(Universidad Nacional Autónoma de México), Paulina Baca(Tufts Medical Center), Diego Aguilar-Ramírez(University of Oxford), Carlos González-Carballo(Universidad Nacional Autónoma de México), Eirini Trichia(University of Oxford), Rory Collins(University of Oxford), Fernando Rivas, Pablo Kuri‐Morales(Universidad Nacional Autónoma de México)
European Heart Journal
October 1, 2024
10.1093/eurheartj/ehae666.2714
Cited by 0

Related Papers

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
|The Lancet|2003|3.8k
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
|The Lancet|2015|3.7k
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
|The Lancet|2005|2.9k
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents
|The Lancet|2016|2.8k
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
|The Lancet|2014|2.7k